Cardiome Pharma Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ADAGE CAPITAL PARTNERS GP LLC, was filed 13 Apr 2009.
Cardiome Pharma Corp: what insiders have been doing
Cardiome Pharma Corp is a listed company. Filings by its managers are published through SEC (Form 4). Cardiome Pharma Corp has had no insider filing for more than a year; the last one goes back to 16 April 2010.
Our records for Cardiome Pharma Corp go back to 2009, with 1 purchase and 2 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Financial data
as of FY 2019FY ended December 2019 · cache
- 650,000 shares@ US$7.92Common Shares, no par valueSEC:0000902664-10-002425:0
- 500,000 shares@ US$7.7601Common Shares, no par valueSEC:0000902664-10-002388:0
- 1,000,000 shares@ US$3.9195Common Shares, no par valueSEC:0000902664-09-001546:0Canonical exit: 8 Jul 2009 (T+90)
3 of 3 declarations
About Cardiome Pharma Corp
Cardiome Pharma Corp is a biopharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on NASDAQ under the ticker CRME.
